Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:10:46.151Z.
Calculation as of: 2026-10-06T14:10:46.151Z.
Quote observation: 2026-10-06T14:10:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 236ecad6846b0cc00793ea2ceb9f38c60eee5e96b58175726d9ae7432cdeb63e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$668.31M
Free Cash Flow Yield
6.07%
TTM Avg
8.57%
3Y Avg
5.30%
5Y Avg
5.30%
Market Cap
$649.13M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$683.14M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$638.20M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$625.03M
Free Cash Flow Yield
N/A
TTM Avg
0.02%
3Y Avg
0.02%
5Y Avg
0.02%
Market Cap
$621.12M
Free Cash Flow Yield
N/A
TTM Avg
2.13%
3Y Avg
14.68%
5Y Avg
12.04%
Market Cap
$620.40M
Free Cash Flow Yield
0.08%
TTM Avg
0.21%
3Y Avg
0.21%
5Y Avg
0.70%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Annexon, Inc. (ANNX) | $665.25M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $668.31M | 6.07% | 8.57% | 5.30% | 5.30% |
| Helus Pharma Inc. (HELP)vs › | $658.52M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $649.13M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $683.14M | N/A | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $625.03M | N/A | 0.02% | 0.02% | 0.02% |
| Fulgent Genetics, Inc. (FLGT)vs › | $621.12M | N/A | 2.13% | 14.68% | 12.04% |
| AngioDynamics, Inc. (ANGO)vs › | $620.40M | 0.08% | 0.21% | 0.21% | 0.70% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $715.02M | N/A | 23.05% | 23.09% | 23.09% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
